Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from ritonavir-boosted protease inhibitor to dolutegravir-based regimen in virologically suppressed HIV patients
TCTR20210625004Phase 3Recruiting
- Sponsor
- Khon Kaen University
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dolutegravir in human immunodeficiency virus infection (HIV), sponsored by Khon Kaen University. Started Apr 2021; status: recruiting.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on TCTR20210625004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210625004.